DH - Definitive Healthcare... Stock Analysis | Stock Taper
Logo
Definitive Healthcare Corp.

DH

Definitive Healthcare Corp. NASDAQ
$1.28 -8.57% (-0.12)

Market Cap $132.23 M
52w High $4.70
52w Low $1.14
P/E -0.74
Volume 604.04K
Outstanding Shares 103.30M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $61.53M $73.54M $-9.31M -15.14% $-0.09 $-6.6M
Q3-2025 $60.05M $59.66M $-14.84M -24.71% $-0.14 $-209K
Q2-2025 $60.75M $50.78M $-7.55M -12.43% $-0.07 $8.52M
Q1-2025 $59.19M $228.55M $-107.23M -181.16% $-0.95 $-149.73M
Q4-2024 $62.29M $147.16M $-59.08M -94.84% $-0.51 $-73.97M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $180.89M $735.49M $356.5M $378.99M
Q3-2025 $185.92M $755.53M $365.86M $284.85M
Q2-2025 $184.2M $770.14M $358.91M $303.62M
Q1-2025 $200.67M $808.66M $372.75M $322.78M
Q4-2024 $290.16M $1.09B $482.19M $444.38M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-17.15M $2.72M $56.35M $-3.91M $55.31M $-1.72M
Q3-2025 $-17.79M $15.69M $24.14M $-12.47M $27.33M $13.41M
Q2-2025 $-9.27M $9.3M $-10.16M $-24.7M $-25.11M $17.01M
Q1-2025 $-155.09M $26.07M $83.55M $-109.71M $721K $18.36M
Q4-2024 $-84.72M $8.13M $-26.27M $-13.37M $-32.23M $-2.77M

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Professional Services
Professional Services
$0 $0 $0 $0
Subscription Services
Subscription Services
$60.00M $60.00M $60.00M $60.00M

Revenue by Geography

Region Q1-2022Q2-2022Q3-2022Q4-2022
NonUS
NonUS
$0 $0 $0 $0
UNITED STATES
UNITED STATES
$50.00M $50.00M $50.00M $60.00M

Q3 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Definitive Healthcare Corp.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

DH combines a strong underlying business model—high gross margins and a subscription-style data platform—with a robust balance sheet marked by high liquidity and very low net debt. Its competitive position benefits from a deep, integrated healthcare dataset, specialized industry focus, and meaningful switching costs for customers. Positive operating and free cash flow, despite reported losses, further underscore the strength of the core cash engine.

! Risks

The most significant risks are the persistent operating and net losses, which highlight an expense base that is too heavy relative to current revenue. Negative retained earnings and reliance on intangibles signal that past performance has not yet produced durable profitability. Competitive and retention pressures, especially indicated by weakening net dollar retention, raise questions about pricing power and long-term customer stickiness. Regulatory and data-privacy developments in healthcare also remain an ongoing structural risk.

Outlook

DH’s outlook hinges on its ability to convert a strong strategic and technological position into sustainable economic returns. If management can stabilize and then improve customer retention, grow revenue on top of the existing base, and bring operating costs more in line with scale, the company’s cash generation and balance sheet give it room to improve financial performance over time. Conversely, if growth and retention do not improve, the current pattern of large losses will become more problematic, even with today’s solid liquidity. The path forward is therefore opportunity-rich but execution-sensitive.